Twelvebees, I think the news would have to come directly from Abbott to be effective.
Abbott has obviously let the world know that they signed a licensing agreement for the Recaf technology so basically the cat is out of the bag.
Although I am not an insider and therefore do not know the strategy that Abbott has in mind, I cannot see what it would hurt for Abbott to say things are going as planned.
The following was noted in a Biocurex press release but it was not on Abbott letterhead so to speak.
We have been asked frequently about the progress of our major licensee. Confidentiality terms preclude us from making any specific comments at this time. We cannot speculate about launching dates, milestone dates or values. Nothing has changed since we signed the agreement with the exception of the work which is advancing. In the most general terms, we are very pleased with the way things are moving along.
News 
Market Data 
Discover 
